Skip to Main Content

Valneva SE American Depositary Shares

VALN Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
VALN Income Statement
VALN Balance Sheet
VALN Cash Flow

Recent trades of VALN by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
VALN Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
VALN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
VALN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by VALN's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Method for rescuing and producing a virus in avian cells Aug. 06, 2024
  • Patent Title: Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus chikv-delta5nsp3 Jun. 18, 2024
  • Patent Title: Aseptic purification process for viruses Apr. 18, 2023
  • Patent Title: Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus chikv-delta5nsp3 Nov. 01, 2022
  • Patent Title: Virus purification Aug. 09, 2022
  • Patent Title: Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus chikv-delta5np3 Jun. 14, 2022
  • Patent Title: Virus purification Dec. 28, 2021
  • Patent Title: Aseptic purification process for viruses May. 26, 2020
  • Patent Title: Virus purification May. 26, 2020
  • Patent Title: Virus purification Jan. 21, 2020
  • Patent Title: Method of making a virus using duck embryonic derived stem cell lines Nov. 21, 2017
  • Patent Title: Production of viral vaccines in suspension on avian embryonic derived stem cell lines Jul. 11, 2017
  • Patent Title: Method of making an avian cell line Jul. 05, 2016
  • Patent Title: Microwell array chip and method of manufacturing same Apr. 12, 2016
  • Patent Title: Generation of duck cell lines Feb. 16, 2016
  • Patent Title: Method of screening by using conformation sensitive peptides Nov. 10, 2015
  • Patent Title: Production of viral vaccines in suspension on avian embryonic derived stem cell lines May. 26, 2015
  • Patent Title: Method of obtaining chicken embryonic stem cells Feb. 24, 2015
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of VALN in WallStreetBets Daily Discussion

VALN News

Recent insights relating to VALN

CNBC Recommendations

Recent picks made for VALN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VALN

VALN Top Shareholders
Shareholder
Shares Held
VALN Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

VALN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view VALN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top